Skip to main content
Log in

Prodrug and antedrug: Two diametrical approaches in designing safer drugs

  • Research Articles Review
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The prodrug and antedrug concepts, which were developed to overcome the physical and pharmacological shortcomings of various therapeutic classes of agents, employ diametrically different metabolic transformations. The prodrug undergoes a predictable metabolic activation prior to exhibiting its pharmacological effects in a target tissue while the antedrug undergoes metabolic deactivation in the systemic circulation upon leaving a target tissue. An increased therapeutic index is the aspiration for both approaches in designing as well as evaluation criteria. The recent research endeavors of prodrugs include the gene-directed and antibodydirected enzymatic activation of a molecule in a targeted tissue, organ specific delivery, improved bioavailabilities of nucleosides and cellular penetration of nucleotides. As for antedrugs, emphasis in research has been based upon the design and synthesis of systemically inactive molecule by incorporating a metabolically labile functional group into an active molecule.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghi, M., Kramm, C. M., Chou, T. C., Breakefield, X. O. and Chiocca, E. A., Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine deaminase gene therapies.J. Natl. Cancer Inst., 90, 370–380 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Albert, A., Chemical aspects of selective toxicity.Nature, 182, 421–423 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Arimilli, M. N., Kim, C. U., Dougherty, J., Mulato, A., Oliyai, R., Shaw, J. P., Cundy, K. C., Bischofberger, N., Synthesis, In Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) Prodrugs.Antiviral Chem. Chemother., 8, 557–564 (1997).

    CAS  Google Scholar 

  • Austin, E. A. and Huber B. E., A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of E. coli cytosine deaminase.Mol. Pharmacol. 43, 380–387 (1993).

    PubMed  CAS  Google Scholar 

  • Avery, M. A. and Woolfrey, J. R., Antiinflammatory steroids. In Wolff, M.E. (Ed.), Medicinal Chemistry and Drug Discovery. John Wiley & Sons, Inc. 281–376 (1997).

  • Bagshawe, K. D. and Begent, R. H. J., First clinical experience with ADEPT.Adv. Drug Delivery Rev., 22, 365–367 (1996).

    Article  CAS  Google Scholar 

  • Bagshawe, K. D., Sharma, S. K., Springer, C. J. and Rogers, G. T., Antibody-Directed Enzyme Prodrug Therapy (ADEPT): a review of some theoretical, experimental and clinical aspects.Analytical Oncology, 5, 879 (1994).

    CAS  Google Scholar 

  • Bagshawe, K. D., Springer, C. J., Searle, R., Antoniw, P., Shama, S. K., Melton, R. G. and Sherwood, R. F., A cytotoxic agent can be generated selectively at cancer sites.Br. J. Cancer, 58, 700–703 (1988).

    PubMed  CAS  Google Scholar 

  • Balzarini, J., Aquaro, S., Perno, C.-F, Witvrouw, M., Holy, A., De Clerq, E., Activity of the (R)-Enantiomers of 9-(2- Phosphonylmethoxypropyl)adenine and 9-(2-Phosphony-lmethoxypropyl)-2,6-Diaminopurine Against Human Immunodeficiency Virus in Different Human Cell Systems.Biochem. Biophys. Res. Comm., 219, 337–341 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Balzarini, J., Egberink, H., Hartmann, K., Cahard, D., Vahlenkamp, T., Thormar, H., De Clercq, E., McGuigan, C., Antiretrovirus Specificity and Intracellular Metabolism of 2,3-Didehydro-2,3-dideoxythymidine (Stavudine) and Its 5- Monophosphate Triester Prodrug So324.Mol. Pharmacol., 50, 1207–1213 (1996b).

    CAS  Google Scholar 

  • Balzarini, J., Egberink, H., Hartmann, K., Karlsson, A., Perno, C.F., Cahard, D., Naesens, L., Thormar, E., De Clercq, E., McGuigan, C., Mechanism of Anti-HIV Action of Masked Alaninyl 2,3-Dideoxy-2,3-Didehydrothymidine 5-Monopho-sphate Derivatives.Antiviral Res., 30, A18 (1996d).

    Google Scholar 

  • Balzarini, J., Holy, A., Jindrich, J., Naesens, L., Snoeck, R., Schols, D., De Clercq E., Differential Antiherpesvirus and Antiretrovirus Effects of the (S) and ® Enantiomers of Acyclic Nucleoside Phosphonates: Potent and Selective In Vitro and In Vivo Antiretrovirus Activities of (R)-9-(2-Phosphonylme-tho-xypropyl)-2,6-Diaminopurine.Antimicrob. Agents and Chemother, 37, 332–338 (1993).

    CAS  Google Scholar 

  • Balzarini, J., Karlsson, A., Aquaro, S., Perno, C.F., Cahard, D., Naesens, L., De Clercq, E., McGuigan, C., Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives.Proc, Natl. Acad. Sci. USA, 93, 7295–7299 (1996a).

    Article  CAS  Google Scholar 

  • Balzarini, J., Kruining, J., Wedgwood, O., Pannecouque, C., Aquaro, S., Perno, C.F., Naessens, L., Witvrouw, M., Heijtink, R., De Clercq, E., McGuigan, C., Conversion of 2, 3- Dideoxyadenosine (ddA) and 2, 3-Didehydro-2, 3-dideo-xyadenosine (d4A) to Their Corresponding Aryloxy-phosphoramidate Derivatives Markedly Potentiates Their Activity Against Human Immunodeficiency Virus and Hepatitis B Virus.FEBS Letters, 410, 324–328 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Balzarini, J., Naesens, L., Slachmuylders, J., Niphuis, H., Rosenburg, I., Holy, A., Schellekens, H., De Clerq, E., 9-(2- Phosphonylmehtoxyethyl)adenine (PMEA) Effectively Inhibits Retrovirus Replication In Vitro and Simian Immunodeficiency Virus Infection in Rhesus Monkeys.AIDS, 5, 21–28 (1991).

    Article  PubMed  CAS  Google Scholar 

  • Balzarini, J., Wedgwood, O., Kruining, J., Pelemans, H., Heijtink, R., De Clercq, E., McGuigan, C., Anti-HIV and Anti- HBV Activity and Resistance Profile of 2, 3-Dideoxy-3- Thiacytidine (3TC) and Its Arylphosphoramidate Derivative CF 1109.Biochem. Biophys. Res. Comm., 225, 363–369 (1996c).

    Article  CAS  Google Scholar 

  • Barnes, P. J., Anti-inflammatory actions of glucocorticoids: molecular mechanisms.Clinical Science, 94, 557–572 (1998).

    PubMed  CAS  Google Scholar 

  • Beaucamp, L. M., Orr, G. F., de Miranda, P., Burnette, T., Krenitsky, T A., Amino Acid Ester Prodrugs of Acyclovir.Antiviral Chem. Chemother, 3, 157–164 (1992).

    Google Scholar 

  • Beltinger, C., Fulda, S., Kammertoens, T., Uckert, W. and Debatin, K. M., Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis.Cancer Res., 60, 3213–3217 (2000).

    Google Scholar 

  • Bentires-Alj, M., Hellin, A. C. and Lechanteur, C., Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.Cancer Gene Ther, 7, 20–26 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Benzaria, S., Pelicano, H., Johnson, R., Maury, G., Imbach, J.L., Aubertin, A.M., Obert, G., Gosselin, G., Synthesis, In Vitro Antiviral Evaluation, and Stability Studies of Bis(S-acyl-2-thioethyl) Ester Derivatives of 9-[2-(Phosphonometho-xy)ethyl]adenine (PMEA) as Potential PMEA Prodrugs with Improved Oral Bioavailability.J. Med. Chem., 39, 4958–4965 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Biggadike, K., Angell, R. M., Burgess, C. M., Farrell, R. M., Hancock, A. P., Harker, A. J., Irving, W. R., loannou, C., Procopiou, P. A., Shaw, R. E., Solanke, Y. E., Singh, O. M. P., Snowden, M. A., Stubbs, R. J., Walton, S. and Weston, H. E., Selective plasma hydrolysis of glucocorticoid g-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism.J. Med. Chem., 43, 19–21 (2000)

    Article  PubMed  CAS  Google Scholar 

  • Biggadike, K., Lynn, S. M., Procopiou, P. A., Shaw, R. E. and Williamson, C.J. Chem. Soc, Perkin Trans. 1, 813–818 (2000).

    Article  Google Scholar 

  • Blakey, D. C., Valcaccia, B. E., East, S., Wright, A. R., Boyle, P. T., Springer, C. J., Burke, P. J., Melton, R.G. and Bagshawe, K.D., Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug.Cell. Biophys., 22, 1–8 (1993).

    PubMed  CAS  Google Scholar 

  • Bloch, A., Robins, M. J., McCarthy, J. R., Jr., The role of the 5- Hydroxyl Group of Adenosine in Determining Substrate Specificity for Adenosine Deaminase.J. Med. Chem., 10, 908–912 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Bodey, G. P., Freireich, E. J., Monto, R. W., Hewlett, J. S., Cytosine Arabinoside (NSC-63878) Therapy For Acute Leukemia in Adults. Cancer Chemother. Rep., 53, 59 (1969).

    PubMed  CAS  Google Scholar 

  • Bodor, N. and Buchwald, P., Soft drug design: general principles and recent applications.Med. Res. Rev., 20(1), 58–101 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Bodor, N., Recent advances in retrometabolic drug design and targeting approaches.Pharmazie, 55(3), 163–166 (2000).

    PubMed  CAS  Google Scholar 

  • Boyd, M. R., Bacon, T. H., Sutton, D., Antiherpesvirus Activity of 9-(4-Hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) in Animals. Antimicrob.Agents Chemother, 32, 358–363 (1988).

    CAS  Google Scholar 

  • Boyd, M. R., Bacon, T H., Sutton, D., Comparative Activity of Penciclovir and Acyclovir in Mice Infected Intraperitoneally with Herpes Simplex Virus Type 1 SC 16. Antimicrob.Agents Chemother, 37, 642–645 (1993).

    Google Scholar 

  • Branson, J. J., Ghazzouli, I., Hitchcock, M. J. M., Russel, J. W., Klunk, L. J., Kern E. R., Martin, J. C., In vivo Anti-retrovirus and Anti-cytomegalovirus Activity of 9-((2-Phosphonylme-thoxy)-ethyl)adenine (PMEA). Abstracts of Papers; 5th International Conference on AIDS, Montreal, Canada, Abstract M.C.P. 74 (1989).

  • Brouilette, G., Kawamura, M., Kumar, G. N. and Bodor, N., Soft drugs. 21. Design and evaluation of soft analogs of propantheline.J. Pharm. Sci. 85, 619 (1996).

    Article  Google Scholar 

  • Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmannn, J. L. and Klatzmann, D., Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.Proc. Natl. Acad. Sci. USA, 90, 7024–7028 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Chu, C. K., Bhadti, V. S., Doshi, K. J., Etse, J. T., Gallo, J. M., Boudinot, F. D., Schinazi, R. R., Brain Targeting of Anti-HIV Nucleosides: Synthesis and In Vitro and In Vivo Studies of Dihydopyridine Derivatives of 3-Azido-2,3-dideoxyuridine and 3-Azido-3-deoxythymidine.J. Med. Chem., 33, 2188–2192 (1990).

    Article  PubMed  CAS  Google Scholar 

  • Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H. and Blaese, R. M., In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.Science, 256, 1550–1552 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Dayer, P., Kubli, A., Kupfer, A., Courvoisier, R., Balant, L. and Fabre, J. Defective hydroxylation of bufuralol associated with side-effects of the drug in poor metabolizers.Br. J. Clin. Pharmacol., 12, 750–751 (1982).

    Google Scholar 

  • De Clerq, E., Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurine and pyrimidines.Biochem. Pharmacol., 42, 963–972 (1991).

    Article  Google Scholar 

  • De Miranda, P., Blum, M. R., Pharmacokinetics of Acyclovir After Intranvenous and Oral Administration.J. Antimicrob. Chemother., 12 (Suppl. B) 29–37 (1983).

    PubMed  Google Scholar 

  • Dessolin, J., Vlieghe, P., Bouygues, M., Medou, M., Quelever, G., Camplo, M., Chermann, J. C., Kraus, J. L., Tri-N-Boc- Tetraazamacrocycle-Nucleoside Conjugates: Synthesis and Anti-HIV Activities.Nucleosides & Nucleotides, 17, 957–968 (1998).

    Article  CAS  Google Scholar 

  • Domin, B. A., Mahony, W. B. and Zimmerman, T. P., Transport of 5-fluorouracil and uracil into human erythrocytes.Biochem. Pharmacol., 46, 503–510 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Elion, G. B., The biochemistry and mechanism of action of acyclovir.Antimicrob. Chemother., 12, Suppl. B:9–17 (1983).

    CAS  Google Scholar 

  • Elshami, A. A., Saavedra, A., Zhang, H., Kucharczuk, J. C., Spray, D. C., Fishman, G. I., Amin, K. M., Kaiser, L. R. and Albeda S. M., Gap junctions play a role in the “bystander effect” of the herpes simplex virus thymidine kinase ganciclovir system in vitro. Gene Then, 3, 85–92 (1996).

    CAS  Google Scholar 

  • Eltahir, A., Heys, S. D., Hutcheon, A. W., Sarkar, T. K., Smith, I., Walker, L. G., Ah-See, A. K. and Eremin, O., Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy.Am. J. Surg., 175, 127–132 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Erhardt, P. W., Woo, C. M., Gorzynski, R. J. and Anderson, W. G., Ultrashort-acting b-adrenergic blocking agent. 1. (Arylo-xy)-propanolamines containing esters in the nitrogen substituent.J. Med. Chem., 25, 1402–1407 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Farquhar, D., Khan, S., Srivastva, D. N., Saunders, P. P., Synthesis and Antitumor Evaluation of Bis[(Pivaloylo-xy)methyl]-2-Deoxy-5-Fluorouridine 5-Monophosphate (Fd- UMP): A Strategy to Introduce Nucleotides into Cells.J. Med. Chem., 37, 3902–3909 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Filer, C. W., Allen, G. D., Brown, T. A., Metabolic and Pharmacokinetic Studies Following Oral Administration of 14C-Famciclovir to Healthy Subjects.Xenbiotica, 24, 357–368 (1994).

    CAS  Google Scholar 

  • Fiorino, T., Current and future treatment of inflammatory bowel disease. Drug & Market Development. 42–48 (2000).

  • Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, R L, Abraham, G. N., The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified.Cancer Res., 53, 5274–5283 (1993).

    PubMed  CAS  Google Scholar 

  • Freeman, S. M., McCune, C., Robinson, W., Abboud, C. N., Abraham, G. N., Angel, C and Marrogi, A., The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study.Hum. Gene Ther, 6, 927–939 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Freeman, S. M., Ramesh, R. and Marrogi, A. J., Immune system in suicide gene therapy.Lancet, 349, 2–3 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Fridland, A., Robbins, B. L., Srinivas, R. V., Arimilli, M., Kim, C., Bischofberger, N., Antiretroviral Activity and Metabolism of bis(POC)PMPA, an Oral Bioavailable Prodrug of PMPA.Antiviral Res., 34, A49, 27 (1997).

    Google Scholar 

  • Friend, D. R., Phillips, S. and Tozer, T. N., Colon-specific drug delivery from a glucoside prodrug in the guinea pig. Efficacy study.J. Control Release, 15, 47–54 (1991).

    Article  CAS  Google Scholar 

  • Frishman, W. H. and Hershman, D., Beta-adrenergic blocking drugs in cardiac disorders. In Cardiovascular Drug Therapy, 2nd ed., Messerli, F. H., Ed.; W. B. Saunders Co., New York, 465–474 (1996).

    Google Scholar 

  • Ge, K., Xu, L., Zheng, Z., Xu, D., Sun, L. and Liu, X., Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine.Int. J. Cancer, 71, 675–679 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Geddes, D. M., Inhaled corticosteroids: Benefits and risks.Thorax, 47, 404–407 (1992).

    PubMed  CAS  Google Scholar 

  • Giradet, J.L., Gosselin, G., Perigaud, O., Balzarini, J., De Clercq, E., Imbach, J.-L,Nucleosides & Nucleotides, 14, 645–647 (1995a).

    Article  Google Scholar 

  • Girardet, J.L., Perigaud, C., Aubertin, A.M., Gosselin, G., Kirn, A., Imbach, J.L.,Bioorg. Med. Chem. Lett., 5, 2981–2984 (1995b).

    Article  CAS  Google Scholar 

  • Hamamoto, U., Nakashima, H., Matsui, A., Matsuda, A., Ueda, T., Yamamoto, N., Inhibitory Effects of 2,3-Didehydro-2,3- Dideoxynucleosides on Infectivity, Cytopathic Effects and Replication of Human Immunodeficiency Virus. Antimicrob.Agents Chemother., 31, 908 (1987).

    Google Scholar 

  • Hamamoto, U., Nakashima, H., Matsui, A., Matsuda, A., Ueda, T., Yamamoto, N., Inhibitory Effects of 2,3-Didehydro-2,3- Dideoxynucleosides on Infectivity, Cytopathic Effects and Replication of Human Immunodeficiency Virus. Antimicrob. Agents Chemother., 31, 908 (1987).

    Google Scholar 

  • Hamilton, T. C. and Parkes, M. W., Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2:Pharmacology. Arzneim.-Forsch. 27, 1410–1417 (1977).

    CAS  Google Scholar 

  • Hanna, N. N., Mauceri, H. J., Wayne, J. D., Hallahan, D. E., Kufe, D. W. and Weichselbaum, R. R., Viral directed cytosine deaminase/5-fluorocytosine gene therapy enhances radia-tion response in human cancer xenografts.Cancer Res., 57, 4205–4209 (1997).

    PubMed  CAS  Google Scholar 

  • Harden, M. R., Jarvest, R. L., Boyd, M. R., Sutton, D., Vere Hodge, R. A., Prodrugs of Selective Antiherpesvirus Agent 9- [4-Hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with Improved Gastrointestinal Absorption Properties.J. Med. Chem., 32, 1738–1743 (1989).

    Article  Google Scholar 

  • Harnden, M. R., Jarvest, R. L., Bacon, T. H., Boyd, M. R., Synthesis and Antiviral Activity of 9 [4-Hydroxy-3- (hydroxymethyl)but-1-yl]purines.J. Med. Chem., 30, 1636–1642 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Harnden, M. R., Jarvest, R. L., Boyd, M. R., Sutton, D., Vere Hodge, R. A., Prodrugs of the Selective Antiherpesvirus Agent 9-[4-Hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with Improved Gastrointestinal Absorption Properties.J. Med. Chem., 33, 1765–1773 (1989a).

    Google Scholar 

  • Harnden, M. R., Jarvest, R. L., Boyd, M. R., Sutton, D., Vere Hodge, R. A., Prodrugs of the Selective Antiherpesvirus Agent 9-[4-Hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with Improved Gastrointestinal Absorption Properties.J. Med. Chem., 32, 1738–1743 (1989b).

    Article  Google Scholar 

  • Heiman, A. S., Hickman, F., Ko, D.-H. and Lee, H. J., New steroidal anti-inflammatory antedrugs bind to macrophage glucocorticoid receptors and inhibit nitric oxide generation.Steroids, 63, 644–649 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Heiman, A. S., Ko, D.-H., Chen, M. and Lee, H. J., New steroidal anti-inflammatory antedrugs: Methyl 3,20-dioxo-9a-fluoro-11b,17a,21-trihydroxy-1,4-pregnadiene-16a-carboxylate and methyl 21-acetyloxy-3,20-dioxo-11b,17a-dihydroxy-9a-fluoro-1,4-pregnadiene-16a-carboxylate.Steroids, 62, 491–499 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Higuchi, T., Stella, V.,Eds. ACS Symp. Ser., no. 14 (1975).

  • Holland, J. R., Glidewell, O., Complementary Chemotherapy in Acute Leukemia.Recent Results Cancer Res., 30, 95 (1970).

    Google Scholar 

  • Hong, C. I., Kirisitis, A. J., Buchheit, D. J., Nechaev, A., West, C. R., 1 b-D-Arabinofuranosylcytosine Conjugates of Thioether Phospholipids as a New Class of Potential Antitumor Drugs.Cancer Drug Delivery, 3, 101–113 (1986).

    PubMed  CAS  Google Scholar 

  • Hong, C. I., Nechaev, A., Kirisits, A. J., Vig, R., West, C. R., Manouilov, K. K., Chu, C. K., Nucleoside Conjugates. 15. Synthesis and Biological Activity of Anti-HIV Nucleoside Conjugates of Ether and Thioether Phospholipids.J. Med. Chem., 39, 1771–1777 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Hong, C. I., Nechaev, A., West, C. R., Nucleoside Conjugates as Potential Antitumor Agents. 2. Synthesis and Biological Activity of 1-(b-D-Arabinofuranosyl)cytosine Conjugates of Prednisolone and Prednisone.J. Med. Chem., 22, 1428–1432 (1979a).

    Article  CAS  Google Scholar 

  • Hong, C. I., Nechaev, A., West, C. R., Nucleoside Conjugates as Potential Antitumor Agents. 2. Synthesis and Biological Activity of 1-(b-D-Arabinofuranosyl)cytosine Conjugates of Prednisolone and Prednisone.J. Med. Chem., 22, 1428–1432 (1979b).

    Article  CAS  Google Scholar 

  • Hortobagyi, G. N., Anthracyclines in the treatment of cancer: an overview.Drugs, 54, 1–7 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Hostetler, K. Y., Richman, D. D., Sridhar, C. N., Gardner, M. R., Antiviral Activity of Phosphatidyl-dideoxycytidine in Hepatitis B Infected Cells and Enhanced Hepatitic Uptake in Mice.Antiviral Res., 24, 59–67 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T. and Good, S. S., Metabolism of 5 fluorocytosine in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.Proc. Natl. Acad. Sci. USA, 91, 8302–8306 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Huber, B. E., Austin, E. S., Good, S. S., Knick, V C, Tibbels, S. and Richards, C. A., In vivo antitumor activity of 5-fluo-rocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.Cancer Res., 53, 4619–4626 (1993).

    PubMed  CAS  Google Scholar 

  • Hwang, S. K., Juhasz, A., Yoon, S. H. and Bodor, N., Design, synthesis and evaluation of soft bufuralol analogues.J. Med. Chem., 43(8), 1525–1532 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Ichikawa, T., Tamiya, T., Adachi, Y., Ono, Y., Matsumoto, K., Furuta, T., Yoshida, Y., Hamada, H. and Ohmato, T., In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.Cancer Gene Ther, 7, 74–82 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Ji Y., Moog, C., Schmitt, G., Bischoff, P., Luu, B., Monophosphoric Acid Diesters of 7b Hydroxycholestrol and of Pyrimidine Nucleosides as Potential Antitumor Agents: Synthesis and Preliminary Evaluation of Antitumor Activity.J. Med. Chem., 33, 2264–2270 (1990).

    Article  PubMed  CAS  Google Scholar 

  • Ji, R., Huang, R., Juhasz, A., Wu, W. and Bodor, N., Design, synthesis and evaluation of soft glycopyrrolate and its analog.Pharmazie., 55(3), 187–191 (2000).

    PubMed  CAS  Google Scholar 

  • Jones, R. J., Arimilli, M. N., Lin, K.-Y, Louie, M. S., McGee, L. R., Shaw, J. -P., Burman, D., Lee, M., Kennedy, J. A., Prisbe, E. J., Bischofberger, N., Lee, W. A., Cundy, K. C., Abstract Op11; XII International Roundtable Nucleosides, Nucleotides and their biological Application, September 15-19, La Jolla, USA (1996).

  • Juhasz, A. and Bodor, N., Cardiovascular studies on different classes of soft drugs.Pharmazie., 55(3), 228–238 (2000).

    PubMed  CAS  Google Scholar 

  • Kanai, F., Lan, K. H., Shiratori, Y., Tanaka, T., Ohashi, M., Okudaira, T., Yoshida, Y., Wakimoto, H., Hamada, H., Nakabayashi, H., Tamaoki, T. and Omata, M., In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.Cancer Res., 57, 461–465 (1997).

    PubMed  CAS  Google Scholar 

  • Kaneko, Y. and Tsukamoto, A., Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir.Cancer Lett., 96, 105–110 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Kerr, D. E., Schreiber, G. J., Vrudhula, V. M., Svensson, H. P., Hellstrom, I., Hellstrom, K. E. and Senter, P. D., Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.Cancer Res., 55, 3558–3563 (1995).

    PubMed  CAS  Google Scholar 

  • Khalil, M. A., Kwon, T. and Lee, H. J., A novel approach to the development of safer anti inflammatory steroids: Antedrugs.Current Topics in Med. Chem., 1, 173–202 (1993).

    Google Scholar 

  • Khalil, M. A., Maponya, M. F., Ko, D.-H., You, Z., Oriaku, E. T. and Lee, H. J., New antiinflammatory steroids: [16a,17a-d]-3- hydroxyiminoformylisoxazoline derivatives of prednisolone and 9a-fluoroprednisolone.Med. Chem. Res., 6, 52–60 (1996).

    CAS  Google Scholar 

  • Kimura, T., Yamaguchi, T., Usuki, K., Kurosaki, Y., Nakayama, T., Fujiwara, Y., Matsuda, Y., Unno, K. and Suzuki, T., Colonic mucosa-specific pro-antedrugs for oral treatment of ulcerative colitis: design, synthesis and fate of methyl 20- glucopyranosyloxyprednisolonates.J. Control Release, 30, 125–135 (1994).

    Article  CAS  Google Scholar 

  • Klatzmann, D., Valery, C. A., Bensimon, G., Marro, B., Boyer, O., Mokhatari, K., Diquet, B., Salzmann, J. L. and Philippon, J., A phase l/ll study of herpes simplex type 1 thymidine kinase “suicide” gene therapy recurrent glioblastoma,Hum. Gene Then., 9, 2595–2604 (1998).

    Article  CAS  Google Scholar 

  • Ko, D.-H., Heima, A. S., Chen, M. and Lee, H. J., New steroidal anti-inflammatory antedrugs: methyl 21-desoxy-21-chloro- 11 b,17a-dihydroxy-3,20-dioxo-1,4-pregnadiene-16a-carboxylate, methyl 21-desoxy-21-chloro-11b-hydroxy-3,20-dioxo-1,4-pregnadiene-16a-carboxylate, and their 9a-fluoro derivatives.Steroids, 65, 210–218 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Ko, D.-H., Heiman, A. S., Hudson, C. E. and Lee, H. J.,New steroidal antiinflammatory antedrugs: methyl 3,20-dioxo-9a-fluoro-11b,17a,21-trihydroxy-1,4-pregnadiene-16a-carboxylate and its 21-O-acyl derivatives.Steroids, in the press (2001).

  • Ko, D.-H., Maponya, M. F., Khalil, M. A., Oriaku, E. T., You, Z. and Lee, H. J., New anti inflammatory steroids: [16a,17a-d]- isoxazoline derivatives of prednisolone and 9a-fluoropre-dnisolone.Med. Chem. Res., 7, 313–323 (1997).

    CAS  Google Scholar 

  • Kodama, K., Morozumi, M., Saitoh, K., Kuninaka, A., Yoshino, H., Saneyoshi, M., Antitumor Activity and Pharmacology of 1- b-D-Arabinofuranosylcytosine-5-stearylphosphate: An Orally Active Derivative of 1-b-D-Arabinofuranosylcytosine.Jpn. J. Cancer Res., 80, 679 (1989).

    PubMed  CAS  Google Scholar 

  • Kuriyama, S., Mitoro, A., Yamazaki, M., Tsujinoue, H., Nakatani, T., Akahane, T., Toyokawa, Y., Kojima, H., Okamoto, S. and Fukui, H., Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.Scand. J. Gastroenterol., 34, 1033–1041 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Kwon T, Heiman A. S., Oriaku E. T., Yoon, K and Lee, H. J., New steroidal antiinflammatory antedrugs: steroidal [16a,17a-d]-3- carbethoxyisoxazolines.J. Med. Chem., 38, 1048–1051 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Labaree, D. C., Reynolds, T. Y and Hochberg, R. B., Estradiol- 16a-carboxylic acid esters as locally active estrogens.J. Med. Chem., 44, 1802–1814 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Lee, H. J. and Ko, D.-H., A novel approach to the discovery of non-systemic anti-inflammatory steroids: Antedrug.Arch. Pharm. Res., 22(3), 279–287 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Lee, H. J. and Soliman, M. R. I., Anti-inflammatory steroids without pituitary adrenal suppression.Science, 215, 989–991 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Lee, H. J., You, Z., Ko, D.-H. and McLean, H. M., Recent advances in prodrugs and antedrugs.Drug Discovery and Development, 1(2), 235–244 (1998).

    CAS  Google Scholar 

  • Lee, H. J., You, Z., Ko, D.-H. and Yoon, K. J., New steroidal anti-inflammatory agents: Prednisolone derivatives with an isoxazoline fusion at the 16- and 17-carbons and an alkyl carboxylate at the 16a-position.Drugs Exptl. Clin. Res., 24(2), 57–66 (1998).

    CAS  Google Scholar 

  • Lefebvre, I., Perigaud, C., Pompon, A., Aubertin, A.M., Girardet, J.L., Kirn, A., Gosselin, G., Imbach, J.L., Mononucleoside Phosphotriester Deravitives with S-Acyl-2-thioethyl Biore-versible Phosphate-Protecting Groups: Intracellular Delivery of 3-Azido-2,3-dideoxythymidine 5-Monophosphate.J. Med. Chem., 38, 3941–3950 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Lewis, L. D., Fowle, A. S. E., Bittiner, S. B., Human Gastrointestinal Absorption of Acyclovir from Tablet Duodenal Infusion and Sipped Solution.Br. J. Clin. Pharmacol., 21, 459–462 (1986).

    PubMed  CAS  Google Scholar 

  • Lipworth, B. J., Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and metaanalysis.Arch. Intern. Med., 159(9), 941–955 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Lorey, M., Meier, C., De Clerq, E., Balzarini, J., New Synthesis and Antitumor Activity of CycloSal-Derivatives of 5-Fluoro-2- deoxyuridinemonophosphate.Nucleosides & Nucleotides, 16, 789–792 (1997).

    Article  CAS  Google Scholar 

  • Lowenthal, R. M. and Eaton, K., Toxicity of chemotherapy.Dematol. Oncol. Clin. North Am., 10, 967–990 (1996).

    Article  CAS  Google Scholar 

  • Manouilov, K. K., Fedorov, I. I., Boudinot, F. D., White, C. A., Kotra, K. P., Schinazi, R. F., Hong, C. I., Chu, C. K., Lymphatic Targeting of Anti-HIV Nucleosides: Distribution of 3-Azido-3-Deoxythymidine (AZT) and 3-Azido-2,3-Deo-xyu-ridine (AzdU) after Administration of Dipalmitoylpho-sphatidyl Prodrugs to Mice.Antiviral Chem. Chemother., 6, 230–238 (1995).

    CAS  Google Scholar 

  • Manouilov, K. K., Xu, Z. S., Boudinot, F. D., Schinazi, R. F. and Chu, C. K. Lymphatic Targeting of Anti-HIV Nucleosides: Distribution of 2,3-Dideoxyinosine after Intravenous and Oral Administration of Dipalmitoylphosphatidyl Prodrug in Mice.Antiviral Res., 34, 91–99 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Mar, E., C, Chiou, J. F., Cheng, Y. C. and Huang, E. S., Human cytomegalovirus-indeced DNA polymerase and its interaction with the triphosphates of 1 -(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-5-methyuracil, -5-iodocytosine, and 5-methylcytosine.J. Virol., 56, 846–851 (1995).

    Google Scholar 

  • Martin-du Pan, R. C., Vonlanthen, M. C. and Dubuis, J. M., Growth and collagen synthesis disorders in asthmatic children treated with inhaled steroids.Rev. Med., Suisse Romande, 119(6), 475–479 (1999).

    CAS  Google Scholar 

  • McGuigan, C., Cahard, D., Sheeka, H. M., De Clercq, E., Balzarini, J., Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite.J. Med. Chem., 39, 1748–1753 (1996).

    Article  PubMed  CAS  Google Scholar 

  • McGuigan, C., Camarasa, M.J., Egberink, H., Hartmann, K., Karlsson, A., Perno, C. F., Balzarini, J., Design, synthesis and biological evaluation of novel nucleotide prodrugs as inhibitors of HIV replication.Int. Antiviral News, 5, 19–21 (1997a).

    Google Scholar 

  • McGuigan, C., Pathirana, R. N., Balzarini, J., De Clercq, E., Intracellular Delivery of Bioactive AZT Nucleotides by Aryl Phosphate Derivatives of AZT.J. Med. Chem., 36, 1048–1052 (1993).

    Article  PubMed  CAS  Google Scholar 

  • McGuigan, C., Tsang, H.-W., Cahard, D., Turner, K., Velazquez, S., Salgado, A., Bidois, L., Naesens, L., De Clercq, E., Balzarini, J., Phosphoramidates Derivatives of d4T as Inhibitors of HIV: The Effect of Amino Acid Variation.Antiviral Res., 35, 195–204 (1997b).

    Article  CAS  Google Scholar 

  • McLean, H. M., Heiman, A. S. and Lee, H. J., Synthesisand pharmacological evaluations of novel conjugates of steroidal antedrugs and non-steroidal anti-inflammatory drugs.Med. Chem. Res., submitted (2001).

  • Meier, C., 4H-1.3.2.-Benzodioxaphosphorin-2-nucleosyl-2-oxide A New Concept for Lipophilic, Potential Prodrugs of Biologically Active Nucleoside Monophosphates.Angew. Chem., 108, 77–79 (1996).

    Article  Google Scholar 

  • Meier, C., De Clerq, E., Balzarini, J., Cyclo-Saligenyl-3-azido- 2,3-dideoxythymidine monophosphate (CycloSal-AZTMP) A New Pro-nucleotide Approach.Nucleosides and Nucleotides, 16, 793–796 (1997c).

    Article  CAS  Google Scholar 

  • Meier, C., Knispel, T., De Clerq, E., Balzarini, J., ADA-Bypass by Lipophilic CycloSal-ddAMP Pro-nucleotides a Second Example of the Efficiency of the CycloSal-concept.Bioorg. Med. Chem. Lett., 7, 1577–1582 (1997d).

    Article  CAS  Google Scholar 

  • Meier, C., Knispel, T., De Clerq, E., Balzarini, J., CycloSal-pronucleotides of 2,3-Dideoxyadenosine and 2, 3-Dideoxy- 2,3-didehydroadenosine: Synthesis and Antiviral Evaluation of a Highly Efficient Nucleotide Delivery System.J. Med. Chem., 42, 1604–1614 (1999a).

    Article  CAS  Google Scholar 

  • Meier, C., Knispel, T., Lorey, M., Balzarini, J., CycloSal- Pronucleotides: The Design and Biological Evaluation of a New Class of Lipophilic Nucleotide Prodrugs.Int. Antiviral News, 5, 183–186 (1997a).

    Google Scholar 

  • Meier, C., Knispel, T., Marquez, V. E., Siddiqui, M. A., De Clerq, E., Balzarini, J., CycloSal-Pronucleotides of 2-Fluoro-ara-and 2-Fluoro-ribo-2,3-dideoxyadenosine as a Strategy to Bypass a Metabolic Blockade.J. Med. Chem., 42, 1615–1624 (1999b).

    Article  CAS  Google Scholar 

  • Meier, C., Lorey, M., De Clerq, E., Balzarini, J., Cyclic Saligenyl Phosphotriesters of 2,3-Dideoxy-2,3-didehydro-thymidine (d4T)-A New Pro-nucleotide Approach.Bioorg. Med. Chem. Lett., 7, 99–104 (1997b).

    Article  CAS  Google Scholar 

  • Meier, C., Lorey, M., De Clerq, E., Balzarini, J., CycloSal-2,3- dideoxy-2,3-didehydrothymidine Monophosphate (CycloSal-d4TMP): Synthesis and Antiviral Evaluation of a New d4TMP Delivery System.J. Med. Chem., 41, 1417–1427 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M. and Vile, R. G., Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.Nat. Med., 4, 581–587 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Melton, R. G. and Sherwood, R. F., Antibody-enzyme conjugates for cancer therapy.Journal of the National Cancer Institute, 88, 153 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Melton, R. G., Searle, R., Sherwood, R. R., Bagshawe, K. D. and Boden, J. A., The potential of carboxypeptidase G2 antibody conjugates as anti-tumour agents. II. In vivo localizing and clearance properties in a choriocarcinoma model.Br. J. Cancer, 61, 420–424 (1990).

    PubMed  CAS  Google Scholar 

  • Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K. and Yamasaki, H., Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.Proc. Natl. Acad. Sci. USA, 93, 1831–1835 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Moolten, F. L., Tumor chemotherapy conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.Cancer Res., 46, 5276–5281 (1986).

    PubMed  CAS  Google Scholar 

  • Mullen, C. A., Coale, M. M., Lowe, R. and Blaese, R. M., Tumor expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.Cancer Res., 54, 1503–1506 (1994).

    PubMed  CAS  Google Scholar 

  • Myles, M. H., Bischofberger, N., Hoover, E. A.,Evaluation of 9- (2-Phosphonyl-methoxypropyl)adenine Antiviral Therapy for Acute Feline Immunodeficiency Virus Infection in Cats. 3rd International Feline Retrovirus Research Symposium 1996, Fort Collins, Col. USA.

  • Nassens, L., Balazarini, J., De Clerq, E., Therapeutic potential of PMEA as an antiviral drug.Med. Virol., 4, 147–159 (1993).

    Article  Google Scholar 

  • Niculescu-Duvaz, I. and Springer, C. J., Development of prodrugs for ADEPT (antibody-directed prodrug therapy).Expert Opinion on Investigational Drugs. 3, 289 (1996).

    Article  Google Scholar 

  • OMalley, B. W. Jr., Chen, S. H., Schwartz, M. R. and Woo, S. L., Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.Cancer Res., 55, 1080–1085 (1995).

    CAS  Google Scholar 

  • Palomino, E., Kessel, D., Horwitz, J. P., A Dihydropyridine Carriers System for Sustained Delivery of 2,3-Dideo-xynucleosides to the Brain.J. Med. Chem., 32, 622 (1989).

    Article  PubMed  CAS  Google Scholar 

  • Pandha, H. S., Martin, L. A., Rigg, A., Hurst, H. C., Stamp, G. W., Sikora, K. and Lemoine, N. R.,J. Clin. Oncol., 17, 2180–2189 (1999).

    PubMed  CAS  Google Scholar 

  • Pannecoucke, X., Parmentier, G., Schmitt, G., Dolle, F., Luu, B., Synthesis of the Phosphodiester of 3b(7b-Hydroxycholestrol) and of 5(3Deoxy, 3Azido-thymidine).Tetrahedron, 50, 1173–1178 (1994).

    Article  CAS  Google Scholar 

  • Pantaleo, G., Graziosi, C., Demarest, J. R., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., Fauci, A. S., HIV Infection is Active and Progressive in Lymphoid Tissue During the Clinical Latent Stage of Disease.Nature, 392, 355–358 (1993).

    Article  Google Scholar 

  • Perigaud, C., Aubertin, A.M., Benzaria, S., Pelicano, H., Girardet, J.L., Maury, G., Gosselin, G., Kirn, A., Imbach, J.L., Equal Inhibition of the Replication of Human Immunodeficiency Virus in Human T-Cell Culture by ddA Bis (SATE) Phosphotriester and 3-Azido-2,3-dideoxythymidin.Biochem. Pharmacol., 48, 11–14 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Perigaud, C., Girardet, J.L., Lefebvre, I., Xie, M.Y., Aubertin, A.M., Kirn, A., Gosselin, G., Imbach, J.L., Sommadossi, J.P., Comparison of Cytotoxicity of Mononucleoside Phosphotriester Derivatives Bearing Biolabile Phosphate Protecting Groups in Normal Human Bone Marrow Progenitor Cells.Antiviral Chem. Chemother., 7, 338–345 (1996).

    CAS  Google Scholar 

  • Perigaud, C., Gosselin, G., Benzaria, S., Girardet, J.L., Maury, G., Pelicano, H., Aubertin, A. M., Kirn, A., Imbach, J.L., Bis(S-Acyl-2Thioethyl)esters of 2,3-Dideoxyadenosine 5-Monophosphate are Potent Anti-HIV Agents in Cell Culture.Nucleosides & Nucleotides, 14, 789–791 (1995).

    Article  CAS  Google Scholar 

  • Perigaud, C., Gosselin, G., Imbach, J.L., Minireview: from the Pronucleotide Concept to the SATE Phosphate Protecting Groups.Curr. Topics in Med. Chem., 2, 15–29 (1997).

    CAS  Google Scholar 

  • Peuch, R., Gosselin, G., Lefebvre, I., Pompon, A., Aubertin, A.M., Kirn, A., Imbach, J.L., Intracellular Delivery of Nucleoside Monophosphates Through a Reductase-Me-diated Activation Process.Antiviral Res., 22, 155–174 (1993).

    Article  Google Scholar 

  • Pompon, A., Lefebvre, I., Imbach, J.-L., Khan, S., Farquhar, D.;Antiviral Chem. Chemother., 5, 91–98 (1994).

    CAS  Google Scholar 

  • Procopiou, P. A., Biggadike, K., English, A. R., Farrell, R. M., Hagger, G. N., Hancock, A. P., Haase, M. V., Irving, W. R., Sareen, M., Snowden, M. A., Solanke, Y. E., Tralau-Stewart, C. J., Walton, S. and Wood, J. A., Novel glucocorticoid antedrugs possessing a 17b-(g-lactone) ring.J. Med. Chem., 44, 602–612 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Pue, M. A., Benet, L. Z., Pharmacokinetics of Famciclovir in Man.Antiviral Chem. Chemother., 4 (Suppl. 1), 47–55 (1993).

    CAS  Google Scholar 

  • Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L M., Katz, D., Blease, R.M. and Oldfield, E. H., Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.Nat. Med., 12, 1354–1361 (1997).

    Article  Google Scholar 

  • Rivera, G., Rhomes, J. A., Dahl, G. V., Pratt, C. B., Wood, A., Avery, T. L., Combined VM-26 and Cytosine Arabinoside in Treatment of Refractory Childhood Lymphocytic Leukemia.Cancer, 45, 1284 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Roche, E. B.,Design of Biopharmaceutical Properties through Prodrugs and Analogs. Academy of Pharmaceutical Sciences Symposium, Washington DC (1977).

  • Rogers, G. T., Burke, P. J., Shama, S. K., Koodie, R. and Boden, J. A., Plasma clearance of an antibody-enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.Br. J. Cancer, 72, 1357–1363 (1995).

    PubMed  CAS  Google Scholar 

  • Rolan, P., Pharmacokinetics of New Antiherpetic Agents.Clin. Pharmacokinet., 29, 333–340 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Sakai, A., Mori, N., Shuto, S., Suzuki, T., Deacylation- Reacylation Cycle: A Possible Absorption Mechanism for the Novel Lymphotropic Antitumor Agent Dipalmitoylphospha-tidylfluorouridine in Rats.J. Pharm. Sci., 83, 575–578 (1993).

    Article  Google Scholar 

  • Sastry, J. K., Nehete, P. N., Khan, S., Nowak, B. J., Plunkett, W., Arlinghaus, R. B., Farquhar, D., Membrane-Permeable Dideoxyuridine 5-Monophosphate Analogue Inhibits Human Immunodeficiency Virus Infection.Mol. Pharmacol., 41, 441–445 (1992).

    PubMed  CAS  Google Scholar 

  • Shama, S. K., Bagshawe, K. D., Burke, P. J., Boden, R. W. and Rogers, G. T., Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localization in a xenograft model.Br. J. Cancer, 61, 659–662 (1990).

    Google Scholar 

  • Shama, S. K., Bagshawe, K. D., Springer, C. J., Burke, P. J., Rogers, G. T., Boden, J. A., Antoniw, P., Melton, R. G. and Sherwood, R. R., Antibody directed enzyme prodrug therapy (ADEPT): a three phase system.Dis. Marker, 9, 225–231 (1991).

    Google Scholar 

  • Shama, S. K., Boden, J. A., Springer, C. J., Burke, P. J. and Bagshawe, K. D., Antibody-directed enzyme prodrug therapy (ADEPT). A three phase study in ovarian tumor xenografts.Cell. Biophys., 24, 219–228 (1994).

    Google Scholar 

  • Shand, N., Weber, R., Mariani, L., Bernstein, M., Gianella-Borradori, A., Long, Z., Sorensen, A. G. and Barbier, N., A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with herpes simplex thymidine kinase gene followed by ganciclovir.Hum. Gene Ther., 10, 2325–2335 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Sharma, A. P., Ollapally, A. P., Lee, H. J., Synthesis and Anti-HIV Activity of Prodrugs of Azidothymidine.Antiviral Chem. Chemother., 4, 93–96 (1993).

    CAS  Google Scholar 

  • Sherwood, R., Melton, R., Alwan, S. and Hughes, P., Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method.Eur. J. Biochem., 148, 447–453 (1985).

    Article  PubMed  CAS  Google Scholar 

  • Shlipak, M. G., Simon, J. A., Vittinghoff, E., Lin, E., Barrett-Conner, E., Knopp, R. H., Levy, R. I. and Hulley, S. B., Estrogen and progestin, lipoprotein (a), and the risk of recurrent coronary heart disease events after menopause.JAMA, 283, 1845–1852 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Shuto, S., Itoh, H., Obara, T., Nakagami, K., Yaso, M., Yaginuma, S., Tsujino, M., Saito, T. New Neplanocin Analogues II. Enzymatic One-Step Synthesis and Antitumor Activity of 6-(3-sn-Phosphatidyl)Neplanocin a Derivatives.Nucleosides & Nucleotides, 11, 437–446 (1992).

    Article  CAS  Google Scholar 

  • Shuto, S., Itoh, H., Ueda, S., Imamura, S., Fukukawa, K., Tsujino, M., Matsuda, A., Ueda, T., A Facile Enzymatic Synthesis of 5-(3-sn-Phosphatidyl)nucleosides and Their Antileukemic Activities.Chem. Pharm. Bull., 36, 209–217 (1988).

    PubMed  CAS  Google Scholar 

  • Siddiqui, A. Q., Ballatore, C., McGuigan, C., De Clerq, E., Balzarini, J., The Presence of Substituents on the Aryl Moiety of the Aryl Phosphoramidate Derivative of d4T Enhances Anti-HIV Efficacy in Cell Culture: A Structure-Activity Relationship.J. Med. Chem., 42, 393–399 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Siemers, N. O., Kerr, D. E., Yarnold, S., Stebbins, M., Vrudhula, V. M., Hellstrom, I., Hellstrom, K. E. and Senter, P. D., Construction, expression, and activities of L49-sFv b-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.Bioconjug. Chem., 8, 510–519 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Smythe, W. R., Hwang, H. C., Elshami, A. A., Amin, K. M., Eck, S. L., Davidson, B. L., Wilson, J. M., Kaiser, L. R. and Albelda, S. M., Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene.Ann. Surg., 222, 78–86 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Soliman, M. R. I. and Lee, H. J., Anti-inflammatory activity of acid ester derivatives of prednisolone.Res. Comm. Chem. Path. Pharm., 33(2), 357–360 (1981).

    CAS  Google Scholar 

  • Springer, C. J. and Niculescu-Duvaz, I., Gene-directed enzyme prodrug therapy (GDEPT): choice of prodrugs.Adv. Drug Deliv. Rev., 22, 351–364 (1996).

    Article  CAS  Google Scholar 

  • Springer, C. J., Dowell, R., Burke, P. J., Hadley, E., Davies, D. H., Blakey, D. C., Melton, R. G. and Niculescu-Duvaz, I., Optimization of alkylating agent prodrugs derived from phenol nad aniline mustards: a new clincal candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).J. Med. Chem., 38, 5051–5065 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Srinivas, R. V., Robbins, B. L., Connelly, M. C., Gong, Y.-F, Bischofberger, N., Fridland, A., Metabolism and In Vitro Antiretroviral Activities of Bis(Pivaloyloxymethyl) Prodrugs of Acyclic Nucleoside Phosphonates.Antimicrob. Agents Chemother., 37, 2247–2250 (1993).

    PubMed  CAS  Google Scholar 

  • Starrett, J. E., Jr., Tortolani, D. R., Russel, J., Hitchcock, M. J. M., Whiterock, V., Martin, J. C., Mansuri, M. M., Synthesis, Oral Bioavailability Determination, and In Vitro Evaluation of Prodrugs of the Antiviral Agent 9-[2-(Phosphonomehtoxy)- ethyl]adenine (PMEA).J. Med. Chem., 37, 1857–1864 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Stribbling, S. M., Friedlos, F., Martin, J., Davies, L., Spooner, R. A., Marais, R. and Springer, C. J., Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect.Hm. Gene Ther., 11, 258–292 (2000).

    Google Scholar 

  • Suzuki, T., Sato, E., Tada, H. and Tojima, Y., Examination of local anti-inflammatory activities of new steroids, hemisuccinyl methyl glycolates.Biol. Pharm. Bull., 22(8), 816–821 (1999a).

    CAS  Google Scholar 

  • Suzuki, T., Tada, H., Sato, E. and Tojima, Y., Examination on biological activities and fates of new steroids, steroid-17-yl methyl glycolates derivatives.Tohoku J. Exptl. Med., 187(2), 127–140 (1999b).

    Article  CAS  Google Scholar 

  • Svensson, H. P., Frank, I. S., Berry, K. K. and Senter, P. D., Therapeutic effects of monoclonal antibody-b-lactamase conjugates in combination with a nitrogen mustard anticacer prodrug in models of human renal cell carcinoma.J. Med. Chem., 41 1507–1512 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Svensson, H. P., Kadow, J. F., Vrudhula, V. M., Wallace, P. M. and Senter, P. D., Monoclonal antibody-b-lactamase conjugates for the activation of a cephalosporin mustard prodrug.Bioconjug. Chem., 3, 176–181 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Tanaka, T., Kanai, F., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Shiratori, Y., Lan, K.-H., Ishitobi, M. and Omata, M., Adenovirus-mediated prodrug gene therapy for car-cinoembryonic antigen-producing human gastric carcinoma cells in vitro.Cancer Res., 56, 1341–1345 (1996).

    PubMed  CAS  Google Scholar 

  • Terrence, P. F., Kinjo, J.E., Lesiak, K., Balazarine, J., De Clerq, E., AIDS Dementia: Synthesis and Properties of a Derivative of 3-Azido-3-Deoxythymidine (AZT) That May Become Locked in the Central Nervous System.FEBS Lett., 234, 135 (1988).

    Article  Google Scholar 

  • Timofeevski, S. L., Panarin, E. F., Vinogradov, O. L. and Nezhentsev, M. V., Anti-inflammatory and antishock water-soluble polyesters of glucocorticoids with low level systemic toxicity.Pharm. Res., 13(3), 476–480 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Tokunaga, Y., Iwasa, T., Fujisaki, J., Sawai, S., Kagayama, A., Liposomal Sustained-Release Delivery Systems for Intravenous Injection. IV. Antitumor Activity of Newly Synthesized Lipophilic 1-b-D-Arabinofuranosylcytosine Prodrug- Bearing Liposomes.Chem. Pharm. Bull., 36, 3574–3583 (1988a).

    CAS  Google Scholar 

  • Tokunaga, Y., Iwasa, T., Fujisaki, J., Sawai, S., Kagayama, A., Liposomal Sustained-Release Delivery Systems for Intravenouslnjection. III. AntitumorActivity of Lipophilic Mitomycin C Prodrug Bearing Liposomes.Chem. Pharm. Bull., 36, 3565 (1988b).

    CAS  Google Scholar 

  • Topf, N., Worgall, N. R., Hackett, N. R. and Crystal, R. G., Regional prodrug gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluo-rocytosine suppresses growth of hepatic metastasis of colon carcinoma.Gene Ther., 5, 507–513 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Torrence, R R, Kinjo, J., Khamnei, S., Greig, N. H., Synthesis and Pharmacokinetics of a Dihydropyridine Chemical Delivery System for the Antiimmunodeficiency Virus Agent Dideoxycytidine.J. Med. Chem., 36, 529–537 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Touraine, R. L., Vahanian, N., Ramsey, W. J. and Blaese, R. M., Enhancement of the herpes simplex virus thymidine kinase ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.Hum. Gene Ther., 9, 2385–2391 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Tsai, C. C., Follis, K. E., Beck, T. W., Sabo, A., Bischofberger, N., Dailey, P. J., Effects of (R)-9-(2-Phosphonylmethoxypro-pyl)adenine Monotherapy on Chronic SIV Infection in Macaques.AIDS Research and Human Retroviruses, 13, 707–712 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Tsai, C. C., Follis, K. E., Sabo, A., Beck, T. W., Grant, R. F., Bischofberger, N., Benveniste, R. E., Black, R., Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphony-lmethoxypropyl)adenine.Science, 270, 1197–1199 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Uchida, K., Krieis, W., Distribution of 1-b-D-Arabinofurano-sylcytosine, Cytidine and Deoxycytidine in Mice Bearing ara- C Sensitive and Resistant P815 Neoplasms.Biochem. Pharmacol., 18, 1115 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Valette, G., Pompon, A., Giradet, J.L., Gosselin, G., Périgaud, C., Gosselin, G., Imbach, J.L., Decomposition Pathways and in vitro HIV Inhibitory Effects of IsoddA Pronucleotides: Toward a Rational Approach for Intracellular Delivery of Nucleoside 5-Monophosphates.J. Med. Chem., 39, 1981–1990 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Van Rompay, K. K. A., Cherrington, J. M., Marthas, M. L., Berardi, C. J., Mulato, A. S., Spinner, A., Tarara, R. P., Canfield, D. R., Telm, S., Bischofberger, N., Pederson, N. C., 9-[2-(Phosphomethoxy)propyl]-adenine Therapy of Established Simian Immunodeficiency Virus Infection in Infant Rhesus Macaques.Antimicrob. Agents Chemother., 40, 2586–2591 (1996).

    PubMed  Google Scholar 

  • Vere Hodge, R. A., Sutton, D., Boyd, M. R., Harnden, M. R., Jarvest, R. L., Selection of an Oral Prodrug (BRL 42810; Famciclovir) for the Antiherpesvirus Agent BRL 39123 [9-(4- Hydroxy-3-hydroxymethylbut-1-yl)guanine; Penciclovir].Antimicrob. Agents Chemother., 33, 1765–1773 (1989).

    PubMed  CAS  Google Scholar 

  • Vrudhula, V. M., Svensson, H. P., Kennedy, K. A., Senter, P. D. and Wallace, P. M., Antitumor activities of a cephalosporin prodrug combination with monoclonal antibody-b-lactamase conjugates.Bioconjug. Chem., 4, 334–340 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Walker, R. E., Vogel, S. E., Jaffe, H.S., Polis, M. A., Kovacs, J., Markowitz, N., Masur, H., Lane, H. C., A Phase l/ll Study of PMEA in HIV Infected Patients.Abstracts of Papers; 1st National Conference on Human Retroviruses and Related Infections, Washington DC (1993).

  • Wei, S. J., Chao, Y., Shih, Y. L., Yang, D. M., Hung, Y M. and Yang, W. K., Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase.Gene Ther., 6, 420–431 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Whitley, R. J., Gnann, J. W., Acyclovir: A Decade Later.N. Engl. J. Med., 327, 782–788 (1992).

    PubMed  CAS  Google Scholar 

  • Xie, H., Voronkov, M., Liotta, D. C., Korba, B. A., Schinazi, R. F., Richman, D. D., Hostetler, K. Y., Phosphatidyl-2, 3-dideoxy- 3-thiacytidine: Synthesis and Antiviral Activity in Hepatitis B- and HIV-1 Infected Cells.Antiviral Res., 28, 113–120 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Yoon, K.-J., Khalil, M. A., Kwon, T. Choi, S.-J. and Lee, H. J., Steroidal anti-inflammatory antedrugs: synthesis and pharmacological evaluation of 16a-alkoxycarbonyl-17-deoxy-prednisolone derivatives.Steroids, 60, 445–451 (1995).

    Article  PubMed  CAS  Google Scholar 

  • You, Z., Heiman, A. S., Chen, M. and Lee, H. J., Novel steroid spiro enones: Consideration of prednisolone derivatives with diethyl oxalate.Steroids, 65, 109–115 (2000).

    Article  PubMed  CAS  Google Scholar 

  • You, Z., Khalil, M. A., Ko, D.-H. and Lee, H. J., Suppression of the Mattox rearrangement of 16a-cyanoprednisolones in acid: synthesis of methyl 16a-prednisolone carboxylates.Tetrahedron Lett., 36(19), 3303–3306 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry J. Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, H.J., Cooperwood, J.S., You, Z. et al. Prodrug and antedrug: Two diametrical approaches in designing safer drugs. Arch Pharm Res 25, 111–136 (2002). https://doi.org/10.1007/BF02976552

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02976552

Key words

Navigation